Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

NCT05911321 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Relapse
Refractory
Aging
Co-morbidity

Interventions

DRUG: Isatuximab
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]